Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

lupin healthcare (uk - desloratadine - tablet - 5mg

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

rosemont pharmaceuticals ltd - desloratadine - oral solution - 500microgram/1ml

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - desloratadine - tablet - 5mg

Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - desloratadine -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - loratadine, quantity: 10 mg - tablet, film coated - excipient ingredients: carnauba wax; lactose monohydrate; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; maize starch; purified talc; silicon dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - in adults and children 12 years and older: treatment of seasonal and perennial allergic rhinitis; relief of symptoms and signs of chronic urticaria.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

apotex nz ltd - loratadine 10mg;  ;  ;   - tablet - 10 mg - active: loratadine 10mg       excipient: croscarmellose sodium hydrated silica lactose monohydrate magnesium stearate microcrystalline cellulose - apo-loratadine is indicated for the relief of: · symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, nasal discharge and itching, and ocular itching and burning. · symptoms and signs of chronic urticaria and other allergic dermatological disorders.

Israel - englanti - Ministry of Health

bayer israel ltd - loratadine; pseudoephedrine sulfate - tablets prolonged release - loratadine 5 mg; pseudoephedrine sulfate 120 mg - loratadine - loratadine - relief of symptoms of seasonal allergic rhinitis when both the antihistaminic properties and the nasal decongestant activity are desired.

Israel - englanti - Ministry of Health

organon pharma israel ltd., israel - desloratadine - tablets - desloratadine 5 mg - desloratadine - desloratadine - aerius tablet is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with:- allergic rhinitis - urticaria

Kanada - englanti - Health Canada

vita health products inc - loratadine - tablet - 10mg - loratadine 10mg - second generation antihistamines

Yhdysvallat - englanti - NLM (National Library of Medicine)

bryant ranch prepack - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary   the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the summed area under the concentration-time curve (auc)-based exposures of desloratadine and its metabolite approximately 320 times that at the recommended human daily oral dose (r